Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 2
1997 1
1998 1
1999 2
2000 3
2001 2
2002 1
2004 3
2006 3
2007 5
2008 14
2009 9
2010 12
2011 17
2012 15
2013 19
2014 13
2015 14
2016 12
2017 2
2018 2
2019 10
2020 11
2021 15
2022 7
2023 8
2024 9

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

198 results

Results by year

Filters applied: . Clear all
Page 1
Global Consensus Position Statement on the Use of Testosterone Therapy for Women.
Davis SR, Baber R, Panay N, Bitzer J, Perez SC, Islam RM, Kaunitz AM, Kingsberg SA, Lambrinoudaki I, Liu J, Parish SJ, Pinkerton J, Rymer J, Simon JA, Vignozzi L, Wierman ME. Davis SR, et al. Among authors: panay n. J Clin Endocrinol Metab. 2019 Oct 1;104(10):4660-4666. doi: 10.1210/jc.2019-01603. J Clin Endocrinol Metab. 2019. PMID: 31498871 Free PMC article.
Global Consensus Position Statement on the Use of Testosterone Therapy for Women.
Davis SR, Baber R, Panay N, Bitzer J, Cerdas Perez S, Islam RM, Kaunitz AM, Kingsberg SA, Lambrinoudaki I, Liu J, Parish SJ, Pinkerton J, Rymer J, Simon JA, Vignozzi L, Wierman ME. Davis SR, et al. Among authors: panay n. Climacteric. 2019 Oct;22(5):429-434. doi: 10.1080/13697137.2019.1637079. Epub 2019 Sep 2. Climacteric. 2019. PMID: 31474158 No abstract available.
Body-identical hormone replacement.
Panay N. Panay N. Climacteric. 2012 Apr;15 Suppl 1:1-2. doi: 10.3109/13697137.2012.669126. Climacteric. 2012. PMID: 22432809 No abstract available.
Efficacy and safety of elinzanetant, a selective neurokinin-1,3 receptor antagonist for vasomotor symptoms: a dose-finding clinical trial (SWITCH-1).
Simon JA, Anderson RA, Ballantyne E, Bolognese J, Caetano C, Joffe H, Kerr M, Panay N, Seitz C, Seymore S, Trower M, Zuurman L, Pawsey S. Simon JA, et al. Among authors: panay n. Menopause. 2023 Mar 1;30(3):239-246. doi: 10.1097/GME.0000000000002138. Epub 2023 Jan 30. Menopause. 2023. PMID: 36720081 Free PMC article. Clinical Trial.
198 results